Research News

  • PACE Studies Seek Feedback on Substance Use and Vape Prevention Messaging
    ​Earlier this spring, the PACE (Policy and Communication Evaluation) Vermont team, led by UVM Associate Professor of Psychiatry and Psychological Science Andrea Villanti, Ph.D., M.P.H., a member of the Vermont Center on Behavior and Health, received funding (R21DA051943, U54DA036114) from the National Institute on Drug Abuse, part of the National Institutes of Health, to conduct two studies: The PACE Vermont Study will assess perceptions and problems associated with vaping in youth and young adults, and the PACE Vape Messaging Study will focus on identifying effective vaping prevention messaging in Vermont young adults. The PACE Vermont team will be recruiting approximately 1,200 youth (aged 12-17) and young adults (aged 18-25) for these two research studies in summer 2020 via pacevt.org.
  • Vermont Integrative Genetics Resource Celebrates Milestones, Grant Support
    Despite the many challenges academic institutions have faced in 2020, the Vermont Integrative Genetics Resource (VIGR) shared core facility at the University of Vermont Cancer Center and Larner College of Medicine has achieved strong funding support and achieved some significant milestones over the past six months.
  • Atherly Receives RWJ Grant to Study Vermont Community Health Teams
    A new, three-year $500,000 grant from the Robert Wood Johnson Foundation will allow members of the UVM Center for Health Services Research (CHSR) at the Larner College of Medicine, led by center director and Professor of Medicine Adam Atherly, Ph.D., to explore the effectiveness of community health teams in improving the quality and efficiency of health care delivery.
  • Atherly Extensively Quoted in Healthcare Innovation Article
    (JUNE 11, 2020) Adam Atherly, Ph.D., professor of medicine and director of the Center for Health Services Research, is quoted extensively in a Healthcare Innovation article, titled “Are Vermont’s Global Budgets, Community Health Teams Improving Outcomes?”
  • Study Highlights Impact of COVID-19 on Tobacco and E-cigarette Use and Motivation to Quit
    A new study from researchers at the Vermont Center on Behavior and Health suggests that, for some, knowledge of COVID-19 is associated with a reduction in cigarette and e-cigarette use, as well as an increase in motivation to quit.
  • Holmes and Stein Named 2020-21 UVM University Scholars
    Larner College of Medicine faculty members Gregory Holmes, M.D., professor and chair of neurological sciences, and Gary Stein, Ph.D., Perelman professor and chair of biochemistry, have been selected as University Scholars for the 2020-21 academic year.
  • American Academy of Arts & Sciences Elects Susan Wallace to Its Membership
    The American Academy of Arts & Sciences has announced the election of University of Vermont Professor of Microbiology and Molecular Genetics Emerita Susan Wallace, Ph.D., to its membership, in recognition of her status as a world leader in the sciences. Wallace joins 275 new members elected on April 23, 2020.
  • Cancer Center Team Presents National Model to Reduce Blood Clots in Patients
    Often-deadly blood clots are a common complication of cancer care, yet less than five percent of patients receive education on how to prevent them. A team of clinician-researchers at the UVM Cancer Center have published an evidence-based prevention “roadmap” found to reduce blood clots by 38 percent in the highest-risk patients.
  • Bates and Vermont Team Invent Emergency Ventilator
    Over the last three weeks, a team of scientists, engineers and doctors at the University of Vermont, including Professor of Medicine Jason Bates, have developed a new design—and built a working model—for a simple, inexpensive ventilator.
  • Dumas and Vanderbilt Colleagues’ Study Examines Menopause and Alzheimer’s Disease
    ​Do the cognitive changes that sometimes occur at menopause relate to an increased risk for Alzheimer’s disease? That’s what a newly launched study, co-led by University of Vermont Associate Professor of Psychiatry Julie Dumas, Ph.D., aims to determine.